Literature DB >> 12174382

Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections.

Wai-Keung Leung1, Lawrence Cheung-Tsui Hung, Carrie Ka-Li Kwok, Rupert Wing-Loong Leong, Daniel Kwok-Keung Ng, Joseph Jao-Yiu Sung.   

Abstract

AIM: The widespread use of antibacterial therapy has been suggested to be the cause for the decline in the prevalence of Helicobacter pylori infection. This study examine the serial changes of urea breath test results in a group of hospitalized patients who were given antibacterial therapy for non-gastric infections.
METHODS: Thirty-five hospitalized patients who were given antibacterial therapy for clinical infections, predominantly chest and urinary infections, were studied. Most (91 %) patients were given single antibiotic of either a penicillin or cephalosporin group. Serial (13)C-urea breath tests were performed within 24 hours of initiation of antibiotics, at one-week and at six-week post-therapy. H. pylori infection was diagnosed when one or more urea breath tests was positive.
RESULTS: All 35 patients completed three serial urea breath tests and 26 (74 %) were H. pylori-positive. Ten (38 %) H. pylori-infected patients had at least one negative breath test results during the study period. The medium delta (13)C values were significantly lower at baseline (8.8) than at one-week (20.3) and six-week (24.5) post-treatment in H. pylori-positive individuals (P=0.022). Clearance of H. pylori at six-week was only seen in one patient who had received anti-helicobacter therapy from another source.
CONCLUSION: Our results suggested that one-third of H. pylori-infected individuals had transient false-negative urea breath test results during treatment with antibacterial agent. However, clearance of H. pylori infection by regular antibiotic consumption is rare.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174382      PMCID: PMC4656324          DOI: 10.3748/wjg.v8.i4.703

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

Review 1.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori.

Authors:  F Mégraud
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

3.  Comparison of two rapid whole-blood tests for Helicobacter pylori infection in Chinese patients.

Authors:  W K Leung; F K Chan; M S Falk; R Suen; J J Sung
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

4.  Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.

Authors:  K Akre; L B Signorello; L Engstrand; R Bergström; S Larsson; B I Eriksson; O Nyrén
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

5.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

6.  Estimates of the worldwide mortality from 25 cancers in 1990.

Authors:  P Pisani; D M Parkin; F Bray; J Ferlay
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

7.  Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.

Authors:  J J Kim; R Reddy; M Lee; J G Kim; F A El-Zaatari; M S Osato; D Y Graham; D H Kwon
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

Review 8.  Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications.

Authors:  H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

9.  Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States.

Authors:  M S Osato; R Reddy; S G Reddy; R L Penland; H M Malaty; D Y Graham
Journal:  Arch Intern Med       Date:  2001-05-14

10.  Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study.

Authors:  T Kumagai; H M Malaty; D Y Graham; S Hosogaya; K Misawa; K Furihata; H Ota; C Sei; E Tanaka; T Akamatsu; T Shimizu; K Kiyosawa; T Katsuyama
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

View more
  6 in total

1.  Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals.

Authors:  H J Windle; Y S Ang; V Athie-Morales; V A Morales; R McManus; D Kelleher
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

2.  Antibiotics taken for other illnesses and spontaneous clearance of Helicobacter pylori infection in children.

Authors:  Cheryl S Broussard; Karen J Goodman; Carl V Phillips; Mary Ann Smith; Lori A Fischbach; R Sue Day; Corinne C Aragaki
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

3.  Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.

Authors:  Die Cheng; Wei-Ren Xu; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

4.  New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.

Authors:  Benjamin D Gold; Mark A Gilger; Steven J Czinn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

5.  Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the ¹³C-Urea breath test.

Authors:  Nilufer Ozaydin; Sinan A Turkyilmaz; Sanda Cali
Journal:  BMC Public Health       Date:  2013-12-21       Impact factor: 3.295

6.  Influence of Dietary Factors on Helicobacter pylori and CagA Seroprevalence in Bulgaria.

Authors:  Daniel Yordanov; Lyudmila Boyanova; Rumyana Markovska; Juliana Ilieva; Nikolay Andreev; Galina Gergova; Ivan Mitov
Journal:  Gastroenterol Res Pract       Date:  2017-06-04       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.